| 000 | 00934 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517112512.0 | ||
| 264 | 0 | _c20180110 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1759-4782 | ||
| 024 | 7 |
_a10.1038/nrclinonc.2016.133 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTopp, Max S | |
| 245 | 0 | 0 |
_aCorrection regarding data on blinatumomab-associated seizures. _h[electronic resource] |
| 260 |
_bNature reviews. Clinical oncology _c10 2016 |
||
| 300 |
_a650 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAntibodies, Bispecific |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma |
| 650 | 0 | 4 | _aSeizures |
| 700 | 1 | _aZimmerman, Zachary | |
| 700 | 1 | _aKantarjian, Hagop M | |
| 773 | 0 |
_tNature reviews. Clinical oncology _gvol. 13 _gno. 10 _gp. 650 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrclinonc.2016.133 _zAvailable from publisher's website |
| 999 |
_c26351112 _d26351112 |
||